CYTOKINETICS INCORPOR
50.25
25-November-24 15:45:01
15 minutes delayed
Stocks
+1.15
+2.34%
Today's range
49.45 - 51.11
ISIN
N/A
Source
NASDAQ
-
19 Oct 2023 06:30:00 By Nasdaq GlobeNewswire
-
06 Oct 2023 11:45:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Host Virtual Investor & Analyst Day on October 19, 2023
05 Oct 2023 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
03 Oct 2023 15:00:00 By Nasdaq GlobeNewswire
-
02 Oct 2023 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Call for Proposals for Its Sixth Annual Communications Grant Program
28 Sep 2023 06:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Participate in Upcoming Investor Conferences
07 Sep 2023 15:00:00 By Nasdaq GlobeNewswire
-
06 Sep 2023 06:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01 Sep 2023 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Reports Second Quarter 2023 Financial Results
03 Aug 2023 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under NASDAQ Listing Rule 5635(C)(4)
01 Aug 2023 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Announce Second Quarter Results on August 3, 2023
27 Jul 2023 15:00:20 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Jul 2023 15:00:00 By Nasdaq GlobeNewswire
-
20 Jun 2023 06:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
02 Jun 2023 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Participate in Upcoming Investor Conferences
01 Jun 2023 15:00:00 By Nasdaq GlobeNewswire
-
15 May 2023 15:00:00 By Nasdaq GlobeNewswire
-
Cytokinetics Announces Initiation of Phase 1 Clinical Study of CK-4021586
11 May 2023 06:30:00 By Nasdaq GlobeNewswire
-
Cytokinetics to Participate in the JMP Securities Life Sciences Conference
08 May 2023 15:00:00 By Nasdaq GlobeNewswire